The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Microenvironmental regulation of therapeutic response in cancer
Open accessAbstract
The tumor microenvironment (TME) not only plays a pivotal role during cancer progression and metastasis but also has profound effects on therapeutic efficacy. In the case of microenvironment-mediated resistance this can involve an intrinsic response, including the co-option of pre-existing structural elements and signaling networks, or an adaptive response of the tumor stroma following the therapeutic insult. Alternatively, in other contexts, the TME has a multifaceted ability to enhance therapeutic efficacy. This review examines recent advances in our understanding of the contribution of the TME during cancer therapy and discusses key concepts that may be amenable to therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–263 of 263
Fernández-L, A., Squatrito, M., Northcott, P. A., Awan, A., Holland, E. C., Taylor, M. D., Nahle, Z. A., & Kenney, A. M. (2011) · Oncogene · doi:10.1038/onc.2011.379 · Cited by 163
Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
Alexander, S., & Friedl, P. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.11.003 · Cited by 160
Orth, J. D., Köhler, R. H., Foijer, F., Sorger, P. K., Weissleder, R., & Mitchison, T. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0412 · Cited by 159
Lakritz, J. R., Poutahidis, T., Levkovich, T., Varian, B. J., Ibrahim, Y. M., Chatzigiagkos, A., Mirabal, S., Alm, E. J., & Erdman, S. E. (2013) · International Journal of Cancer · doi:10.1002/ijc.28702 · Cited by 158
Jamal, M., Rath, B. H., Tsang, P. S., Camphausen, K. A., & Tofilon, P. J. (2012) · Neoplasia · doi:10.1593/neo.111794 · Cited by 157
Antiangiogenic therapy—evolving view based on clinical trial results
Jayson, G. C., Hicklin, D. J., & Ellis, L. M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.8 · Cited by 154
Surgery, wound healing, and metastasis: Recent insights and clinical implications
Ceelen, W. P., Pattyn, P., & Mareel, M. M. K. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.008 · Cited by 151
Dekker, T. J. A., van de Velde, C. J. �., van Pelt, G. W., Kroep, J. R., Julien, J. P., Smit, V. T. H. B. M., Tollenaar, R. A. �. �., & Mesker, W. E. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2571-5 · Cited by 150
Voorhees, P. M., Manges, R., Sonneveld, P., Jagannath, S., Somlo, G., Krishnan, A. Y., Lentzsch, S., Frank, R. C., Zweegman, S., Wijermans, P., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12266 · Cited by 149
Miguel, J. F. S., Bladé, J., Shpilberg, O., Grosicki, S., Maloisel, F., Min, C., Zarzuela, M. P., Robak, T., Prasad, S. V. S. S., Goh, Y. T., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546374 · Cited by 148
Engineered Culture Models for Studies of Tumor-Microenvironment Interactions
Infanger, D. W., Lynch, M. E., & Fischbach, C. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150028 · Cited by 135
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity
de Oliveira, R. L., Deschoemaeker, S., Henze, A., Debackere, K., Finisguerra, V., Takeda, Y., Roncal, C., Dettori, D., Tack, E., Jönsson, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.028 · Cited by 133
Devaud, C., Westwood, J. A., John, L. B., Flynn, J. K., Paquet‐Fifield, S., Duong, C. P. M., Yong, C. S. M., Pegram, H. J., Stacker, S. A., Achen, M. G., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.219 · Cited by 131
Microparticle‐associated nucleic acids mediate trait dominance in cancer
Jaiswal, R., Gong, J., Sambasivam, S., Combes, V., Mathys, J., Davey, R., Grau, G. E., & Bebawy, M. (2011) · The FASEB Journal · doi:10.1096/fj.11-186817 · Cited by 123
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Shang, Y., Cai, X., & Fan, D. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113136660097 · Cited by 122
Interstitial fluid: the overlooked component of the tumor microenvironment?
Wiig, H., Tenstad, O., Iversen, P. O., Kalluri, R., & Bjerkvig, R. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-12 · Cited by 120
Lapatinib and doxorubicin enhance the S tat1‐dependent antitumor immune response
Hannesdóttir, L., Tymoszuk, P., Parajuli, N., Wasmer, M.-H., Philipp, S., Daschil, N., Datta, S., Koller, J., Tripp, C. H., Stoitzner, P., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242505 · Cited by 115
Mueller, K. L., Madden, J. M., Zoratti, G. L., Kuperwasser, C., List, K., & Boerner, J. L. (2012) · Breast Cancer Research · doi:10.1186/bcr3224 · Cited by 115
Wege, A. K., Ernst, W., Eckl, J., Frankenberger, B., Vollmann‐Zwerenz, A., Männel, D. N., Ortmann, O., Kroemer, A., & Brockhoff, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26159 · Cited by 112
Mannino, M., & Chalmers, A. J. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.05.001 · Cited by 112
Hecht, J. R., Mitchell, E., Neubauer, M. A., Burris, H. A., Swanson, P., Lopez, T., Buchanan, G., Reiner, M., Gansert, J., & Berlin, J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2017 · Cited by 110
Lai, C.-Y., Schwartz, B. E., & Hsu, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0624 · Cited by 110
Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis
Kinoshita, H., Hirata, Y., Nakagawa, H., Sakamoto, K., Hayakawa, Y., Takahashi, R., Nakata, W., Sakitani, K., Serizawa, T., Hikiba, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060914 · Cited by 106
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 104
Song, L., Smith, M. A., Doshi, P. D., Sasser, K., Fulp, W. J., Altiok, S., & Haura, E. B. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000193 · Cited by 101
Lesniak, D. M., Xu, Y., Deschênes, J., Lai, R. L., Thoms, J., Murray, D., Gosh, S., Mackey, J. R., Sabri, S., & Abdulkarim, B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1591 · Cited by 99
Mink, S. R., Vashistha, S., Zhang, W., Hodge, A., Agus, D. B., & Jain, A. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0460 · Cited by 98
CTen: a web-based platform for identifying enriched cell types from heterogeneous microarray data
Shoemaker, J. E., Lopes, T. J. S., Ghosh, S., Matsuoka, Y., Kawaoka, Y., & Kitano, H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-460 · Cited by 97
Probabilistic analysis of gene expression measurements from heterogeneous tissues
Erkkilä, T., Lehmusvaara, S., Ruusuvuori, P., Visakorpi, T., Shmulevich, I., & Lähdesmäki, H. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq406 · Cited by 90
Guérin, É., Man, S., Xu, P., & Kerbel, R. S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4183 · Cited by 86
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 86
Molecular Pathways: Involving Microenvironment Damage Responses in Cancer Therapy Resistance
Sun, Y., & Nelson, P. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0768 · Cited by 80
Carcinoma cells misuse the host tissue damage response to invade the brain
Chuang, H., van Rossum, D., Sieger, D., Siam, L., Klemm, F., Bleckmann, A., Bayerlová, M., Farhat, K., Scheffel, J., Schulz, M., et al. (2013) · Glia · doi:10.1002/glia.22518 · Cited by 78
Self-citationBreast Cancer: Should Gastrointestinal Bacteria Be on Our Radar Screen?
Rao, V. P., Poutahidis, T., Fox, J. G., & Erdman, S. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3468 · Cited by 77
Twisted tango: brain tumor neurovascular interactions
Hjelmeland, A. B., Lathia, J. D., Sathornsumetee, S., & Rich, J. N. (2011) · Nature Neuroscience · doi:10.1038/nn.2955 · Cited by 76
Six-color intravital two-photon imaging of brain tumors and their dynamic microenvironment
Ricard, C., & Debarbieux, F. C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00057 · Cited by 75
Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution
Campbell, I., Polyák, K., & Haviv, I. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4253 · Cited by 74
Deconstructing Signaling in Three Dimensions
Rubashkin, M. G., Ou, G., & Weaver, V. M. (2014) · Biochemistry · doi:10.1021/bi401710d · Cited by 72
Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells
Bergfeld, S. A., Blavier, L., & DeClerck, Y. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0400 · Cited by 72
Predictive Biomarkers for Bevacizumab: Are We There Yet?
Maru, D. M., Venook, A. P., & Ellis, L. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3409 · Cited by 70
Li, L., & Lu, Y. (2011) · Journal of Cancer · doi:10.7150/jca.2.458 · Cited by 67
Azreq, M.-A. E., Naci, D., & Aoudjit, F. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0132 · Cited by 65
Perivascular stem cell niche in head and neck cancer
Ritchie, K., & Nor, J. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.025 · Cited by 63
Pasquier, J., Al-Thawadi, H., Ghiabi, P., Abu-Kaoud, N., Maleki, M., Guerrouahen, B. S., Vidal, F., Courderc, B., Ferron, G., Martínez, A., et al. (2014) · Cancer Microenvironment · doi:10.1007/s12307-013-0142-2 · Cited by 62
Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging, and Therapeutic Targets
Koumenis, C., Hammond, E. M., & Giaccia, A. J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6 · Cited by 60
Novel 3D Co-Culture Model for Epithelial-Stromal Cells Interaction in Prostate Cancer
Fang, X., Sittadjody, S., Gyabaah, K., Opara, E. C., & Balaji, K. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075187 · Cited by 60
Curigliano, G., Petit, J., Bertolini, F., Colleoni, M. A., Peruzzotti, G., de Braud, F., Gandini, S., Giraldo, A., Martella, S., Orlando, L., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-3381-1 · Cited by 59
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Ma, Y., Aymeric, L., Locher, C., Mattarollo, S. R., Delahaye, N. F., Pereira, P., Boucontet, L., Apétoh, L., Ghiringhelli, F., Casares, N., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.201002692084c · Cited by 58
Carito, V., Bonuccelli, G., Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Caroleo, M. C., Cione, E., Howell, A., Pestell, R. G., Lisanti, M. P., & Sotgia, F. (2012) · Cell Cycle · doi:10.4161/cc.21701 · Cited by 57
Radiotherapy and the Tumor Microenvironment: Mutual Influence and Clinical Implications
Thompson, R. F., & Maity, A. M. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_7 · Cited by 54
Goel, H. L., Sayeed, A., Breen, M., Zarif, M. J., Garlick, D. S., Leav, I., Davis, R. J., FitzGerald, T. J., Morrione, A., Hsieh, C., et al. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24323 · Cited by 54
The mesenchymal tumor microenvironment: A drug-resistant niche
Cukierman, E., & Bassi, D. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20210 · Cited by 53
Cancer Metabolism: New Validated Targets for Drug Discovery
Sotgia, F., Martinez‐Outschoorn, U., & Lisanti, M. P. (2013) · Oncotarget · doi:10.18632/oncotarget.1182 · Cited by 44
Therapeutic Targeting of Tumor-associated Macrophages and Microglia in Glioblastoma
Bowman, R. L., & Joyce, J. A. (2014) · Immunotherapy · doi:10.2217/imt.14.48 · Cited by 44
Self-citationWeisberg, E., Liu, Q., Zhang, X., Nelson, E. A., Sattler, M., Liu, F., Nicolais, M., Zhang, J., Mitsiades, C. S., Smith, R. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056473 · Cited by 43
Hitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche
Brooks, M. D., Sengupta, R., Snyder, S. C., & Rubin, J. B. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0012-0 · Cited by 42
Roderfeld, M., Räth, T., Lammert, F., Dierkes, C., Graf, J., & Roeb, E. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i5.175 · Cited by 41
Meng, W., Wu, Y., He, X., Liu, C., Gao, Q., Lin, G., Wu, L., Liu, Y., Guo, Y., Li, X., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2275 · Cited by 41
Marchini, C., Montani, M., Konstantinidou, G., Orrù, R., Mannucci, S., Ramadori, G., Gabrielli, F., Baruzzi, A., Berton, G., Merigo, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014131 · Cited by 38
The significance of the senescence pathway in breast cancer progression
Pare, R. B., Yang, T., Shin, J., & Lee, C. S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201081 · Cited by 30
Sharma, N., Wesolowski, R., Reebel, L., Rodal, M. B., Alexandra, P., West, B. L., Karlin, D. A., Dowlati, A., Le, M. H., Coussens, L. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.tps3127 · Cited by 11
Suppression of Hedgehog signalling promotes pro‐tumourigenic integrin expression and function
Moutasim, K. A., Mellows, T., Mellone, M., Lopez, M., Tod, J., Kiely, P., Sapienza, K., Greco, A., Neill, G. W., Violette, S. M., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4342 · Cited by 7
Aberrant type I and type III collagen gene expression in human breast cancerin vivo
Kauppila, S., Stenbäck, F., Risteli, J., Jukkola, A., & Risteli, L. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(1998110)186:3
Cited by
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Self-citationGeller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
Self-citationOrganoid modeling of the tumor immune microenvironment
Neal, J. T., Li, X., Zhu, J., Giangarra, V., Grzeskowiak, C. L., Ju, J., Liu, I. H., Chiou, S.-H., Salahudeen, A. A., Smith, A. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.021 · Cited by 1,556
Metadata
- Authors
- Klemm, F., & Joyce, J. A.
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 25
- Issue
- 4
- Pages
- 198-213
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W2087690546
- Cited by
- 771
- References
- 263
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.